Ophthalmic composition for the treatment of visual disorders
US-2024335458-A1 · Oct 10, 2024 · US
Methods for treatment of autism spectrum disorder
US8987246B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8987246-B2 |
| Application number | US-201313945384-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 18, 2013 |
| Priority date | Jul 18, 2012 |
| Publication date | Mar 24, 2015 |
| Grant date | Mar 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to the field of autism. More specifically, the present invention provides methods for treating individuals with autism spectrum disorder. Accordingly, in one aspect, the present invention provides methods for treating patients with autism spectrum disorder. In one embodiment, a method for treating an autism spectrum disorder (ASD) in a patient comprises the step of administering a therapeutically effective amount of cholesterol to the patient. In more specific embodiments, the ASD is autism, Asperger's disorder, pervasive developmental disorder-not otherwise specified (PDD-NOS), Rett's syndrome and childhood disintegrative disorder. In one embodiment, the patient has autism.
First claim
Opening claim text (preview).
We claim: 1. A method for treating a patient having ASD but not SLOS comprising the step of administering a therapeutically effective amount of cholesterol to the patient. 2. A method for treating a patient having ASD, normal cholesterol levels, and who does not have SLOS comprising the step of administering a therapeutically effective amount of cholesterol to the patient. 3. A method for treating a patient having ASD, low cholesterol levels,…
Assignees
Inventors
Classifications
- A61K31/575Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8987246B2 cover?
- The present invention relates to the field of autism. More specifically, the present invention provides methods for treating individuals with autism spectrum disorder. Accordingly, in one aspect, the present invention provides methods for treating patients with autism spectrum disorder. In one embodiment, a method for treating an autism spectrum disorder (ASD) in a patient comprises the step of…
- Who is the assignee on this patent?
- Univ Johns Hopkins, Kennedy Krieger Inst Inc, Nat Inst Health
- What technology area does this patent fall under?
- Primary CPC classification A61K31/575. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).